This case is being described as nothing short of extraordinary.Dr. John Campbell reviews a study involving an 83-year-old woman diagnosed with stage 4 breast cancer that had spread to her liver, spine, and bones—typically considered a terminal condition.According to the report, she took a daily dose of 222 mg of fenbendazole for eight months. Over that period, her liver enzyme levels returned to normal, and her tumor marker dropped significantly from 316 to 36.Most strikingly, follow-up assessme